We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00005991
Recruitment Status : Completed
First Posted : February 25, 2004
Last Update Posted : October 10, 2012
Sponsor:
Collaborator:
Information provided by (Responsible Party):